Cancer research increasingly depends on models that can capture the complexity of living tumors, including three-dimensional (3D) architecture, extracellular matrix cues, immune interactions, and patient-specific biology. 3D bioprinting offers a powerful way to build controlled tumor models that more closely reflect the physical and cellular environments found in cancer tissues.
This compendium examines how bioprinted 3D cancer models can be combined with multiomics analyses, tumor microenvironment modeling, and therapeutic screening approaches to investigate patient-specific treatment responses, immunotherapy performance, and antibody drug efficacy in clinically relevant contexts.
Download this compendium to learn:
- How 3D bioprinting can be used to create physiologically relevant tumor models
- How multicellular tumor microenvironment models enable the study of interactions between cancer, stromal, and immune cells
- How advanced 3D models can be integrated with imaging, multiomics, and drug screening to investigate therapy responses
